Entrada Therapeutics (TRDA) Stock Chart & Stock Price History $8.13 +0.27 (+3.44%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$8.14 +0.00 (+0.06%) As of 04/17/2025 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entrada Therapeutics Stock Price Performance 5 Day Performance+2.91%1 Month Performance-22.28%3 Month Performance-35.93%6 Month Performance-53.38%Year-To-Date Performance-52.98%1 Year Performance-31.74% Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address TRDA Stock Chart for Friday, April, 18, 2025 TRDA Chart by TradingView Entrada Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2025$7.86$8.13+3.44%$8.38$7.79158,883 shs$305.65 million04/16/2025$7.87$7.86-0.13%$7.89$7.56179,751 shs$295.50 million04/15/2025$7.92$7.87-0.63%$8.03$7.75167,832 shs$295.87 million04/14/2025$7.90$7.92+0.25%$8.09$7.70192,683 shs$297.75 million04/11/2025$7.85$7.90+0.64%$8.14$7.54175,185 shs$297 million04/10/2025$8.27$7.85-5.08%$8.24$7.66447,192 shs$295.12 million04/09/2025$7.55$8.27+9.54%$8.47$7.10185,214 shs$310.91 million04/09/2025$7.55$8.27+9.54%$8.47$7.10185,214 shs$310.91 million04/08/2025$8.19$7.55-7.81%$8.72$7.44176,614 shs$283.84 million04/08/2025$8.19$7.55-7.81%$8.72$7.44176,614 shs$283.84 million Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/07/2025$7.94$8.19+3.15%$8.60$7.42229,398 shs$307.90 million04/04/2025$8.02$7.94-1.00%$7.99$7.52175,156 shs$298.50 million04/03/2025$8.80$8.02-8.86%$8.55$7.93239,879 shs$301.51 million04/02/2025$8.76$8.80+0.46%$8.89$8.59167,060 shs$330.84 million04/01/2025$9.04$8.76-3.10%$9.44$8.73148,240 shs$329.33 million03/31/2025$9.56$9.04-5.44%$9.43$8.85143,370 shs$339.86 million03/28/2025$9.96$9.56-4.02%$9.92$9.5166,723 shs$359.41 million03/27/2025$9.90$9.96+0.61%$10.06$9.7989,226 shs$374.45 million03/26/2025$10.18$9.90-2.75%$10.29$9.7585,576 shs$372.19 million03/25/2025$10.80$10.18-5.74%$10.87$10.0866,913 shs$382.72 million03/24/2025$10.49$10.80+2.96%$10.81$10.6174,114 shs$406.03 million03/21/2025$10.41$10.49+0.77%$10.80$10.15205,190 shs$394.37 million03/20/2025$10.75$10.41-3.16%$11.04$10.3767,273 shs$391.36 million03/19/2025$10.46$10.75+2.77%$10.78$10.31128,848 shs$404.15 million03/18/2025$10.81$10.46-3.24%$10.74$10.2859,455 shs$393.24 million03/17/2025$10.81$10.81$11.36$10.5380,582 shs$406.40 million Related Companies Calliditas Therapeutics AB (publ) Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Adaptive Biotechnologies Stock Price Chart Ardelyx Stock Price Chart Evotec Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Qilian International Holding Group Stock Price Chart Ocular Therapeutix Stock Price Chart Iovance Biotherapeutics Stock Price Chart Syndax Pharmaceuticals Stock Price Chart Receive TRDA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRDA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen your...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entrada Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.